South Africa is in the process of finalising a R25 million investment to boost pan-African Covid-19 vaccine manufacturing capabilities.
“We are currently in the process of finalising a R25 million investment to boost pan-African vaccine manufacturing capabilities through the African Renaissance Fund.” “As the international community, we have been unanimous that services, supplies, products and technologies for prevention, treatment and care of COVID-19 must be available to all. No country must be left behind.”
“One looks for instance at the advances in ventilator development and production in developing countries.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오: